Skip to main content
Log in

Sexual medicine

The psychological effects of recreational PDE5 inhibitor use

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

The availability of PDE5 inhibitors has significantly altered the way in which erectile dysfunction (ED) is treated. Some major issues have emerged since the advent of PDE5 inhibitor use for ED, especially in relation to recreational use in young, healthy men and the role of confidence in erectile ability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Althof, S. E. When an erection alone is not enough: biopsychosocial obstacles to lovemaking. Int. J. Impot. Res. 14, S99–104 (2002).

    Article  PubMed  Google Scholar 

  2. Harte, C. B. & Meston, C. M. Recreational use of erectile dysfunction medications and its adverse effects on erectile function in young healthy men: the mediating role of confidence in erectile ability. J. Sex. Med. 9, 1852–1859 (2012).

    Article  PubMed  Google Scholar 

  3. Melnik, T., Abdo, C. H., de Moraes, J. F. & Riera, R. Satisfaction with the treatment, confidence and 'naturalness' in engaging in sexual activity in men with psychogenic erectile dysfunction: preliminary results of a randomized controlled trial of three therapeutic approaches. BJU Int. 109, 1213–1219 (2012).

    Article  PubMed  Google Scholar 

  4. Harte, C. B. & Meston, C. M. Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors. Arch. Sex. Behav. 40, 597–606 (2011).

    Article  PubMed  Google Scholar 

  5. Korkes, F., Costa-Matos, A., Gasperini, R., Reginato, P. V. & Perez, M. D. C. Recreational use of PDE5 inhibitors by young healthy men: recognizing this issue among medical students. J. Sex. Med. 5, 2414–2418 (2008).

    Article  PubMed  Google Scholar 

  6. Bechara, A., Casabé, A., De Bonis, W., Helien, A. & Bertolino, M. V. Recreational use of phosphodiesterase type 5 inhibitors by healthy young men. J. Sex. Med. 7, 3736–3742 (2010).

    Article  PubMed  Google Scholar 

  7. Cachay, E., Mar-Tang, M. & Mathews, W. C. Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care STDS 18, 349–354 (2004).

    Article  PubMed  Google Scholar 

  8. Swearingen, S. G. & Klausner, J. D. Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am. J. Med. 118, 571–577 (2005).

    Article  CAS  PubMed  Google Scholar 

  9. Melnik, T., Soares, B. G. & Nasello, A. G. The effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernosal injection, and vacuum devices. J. Sex. Med. 5, 2562–2574 (2008).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melnik, T. The psychological effects of recreational PDE5 inhibitor use. Nat Rev Urol 9, 479–480 (2012). https://doi.org/10.1038/nrurol.2012.149

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2012.149

  • Springer Nature Limited

Navigation